Other
NBO
NBO is an intervention with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Active Trials
1(33%)
Phase Distribution
Ph phase_2
1
33%
Ph phase_3
2
67%
Phase Distribution
0
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 3Large-scale testing
2(66.7%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Other(1)
Detailed Status
Recruiting1
unknown1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 21 (33.3%)
Phase 32 (66.7%)
Trials by Status
recruiting133%
unknown133%
not_yet_recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingphase_3
Normobaric Oxygen in AIS Transferred for EVT
NCT06666764
not_yet_recruitingphase_3
Adjuvant Cerebroprotection Using Normobaric Hyperoxia in Pre-hospital Patients with Suspected Stroke
NCT06801457
unknownphase_2
The Prehospital Administration of Normobaric Oxygen in Suspected Stroke
NCT05351073
Clinical Trials (3)
Showing 3 of 3 trials
NCT06666764Phase 3
Normobaric Oxygen in AIS Transferred for EVT
NCT06801457Phase 3
Adjuvant Cerebroprotection Using Normobaric Hyperoxia in Pre-hospital Patients with Suspected Stroke
NCT05351073Phase 2
The Prehospital Administration of Normobaric Oxygen in Suspected Stroke
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3